Intermittent Normoxia Reduces Myocardial Reperfusion Injury

Status Unknown status

Clinical Trial Summary

This study aims to determine the effect of intermittent normoxic cardiopulmonary bypass (CPB) on inflammatory response, oxidative stress and myocardial reperfusion injury in adult patients undergoing valve replacement. The investigators hypothesized that nuclear factor kappa B (NFkB) was involved in regulating gene expression of myocardial inflammatory factor.

Clinical Trial Description

Methods:Patients meeting the requirement will be randomized into 2 groups: the control group received hyperoxic reperfusion (PaO2 180-250 mmHg) throughout CPB as routine; the treatment group underwent 3 cycles of 5/5 min normal/high oxygenation (PaO2 80-150/180-250 mmHg) during cardioplegia arrest, and maintained the same hyperoxia as the control group in the rest time of CPB. The clinical data of inotropes requirement, drainage, ventilation and intensive care time will be recorded. Venous blood samples will be taken perioperatively for detecting concentration of troponin I (cTnI), tumor necrosis factor-α , interleukin-6, 10, and malondialdehyde (MDA). Atrial biopsies will be removed before cardioplegia arrest and 30min after aortic de-clamping to determine the extent of neutrophil infiltration (myeloperoxidase activity), NFkB binding DNA activity, and gene expression of inflammatory factors (TNF-α, IL-6, 10).

Statistical analysis:A sample size of at least 32 patients in each group was needed to have a power of 90%, significance at the two-side 5% level, on the basis that a SD of 0.2 ng/ml and a difference in peak serum cTnI release of about 0.15 ng/ml between control and conditioned patients was determined.

Expected Results: The treatment group will have significantly lower release of cTnI, inflammatory factors, and MDA during CPB and afterwards. Intermittent normoxia may be related to less myocardial inflammation characterized by decreased myeloperoxidase activity, gene expression of inflammatory factors, the later may result from reduced activity of NFkB binding to DNA after reperfusion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01348906
Study type	Interventional
Source	Central South University
Contact	Shengxi Chen, M.D.
Phone	86-731-89753413
Email	shengxi.chen@hotmail.com
Status	Unknown status
Phase	N/A
Start date	May 2011
Completion date	July 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04291911` - Retrospective Multicentre Observational Study on the Incidence of Hyperoxia in Non-intubated Patients in Intensive Care in Belgium Study OxSIZgen
Completed	`NCT02917668` - Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Cardiac Surgery Patients	N/A
Not yet recruiting	`NCT02201875` - Intrinsic Periodic Pattern of Breathing	N/A
Completed	`NCT05770583` - The Effectiveness of FiO2 Titration Guided by the Oxygen Reserve Index in Preventing Hyperoxia.	N/A
Not yet recruiting	`NCT02553668` - Proteomics for Identification of Hyperoxia-induced Changes in Protein Expression	N/A
Completed	`NCT01978158` - Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α	Phase 1/Phase 2
Completed	`NCT03268590` - Neuroimaging During Pure Oxygen Breathing	Phase 4
Active, not recruiting	`NCT04133740` - Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study	Phase 4
Recruiting	`NCT04866342` - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor	N/A
Completed	`NCT05150418` - Supplemental Oxygen in Hypovolemia	Phase 1
Terminated	`NCT03550469` - Computer-assisted Oxygen Therapy Weaning in Critically Ill Children	N/A
Recruiting	`NCT04413097` - Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants	N/A
Completed	`NCT03464695` - Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD	N/A
Recruiting	`NCT04269161` - NICU Oxygen Control Study	N/A
Completed	`NCT02384616` - Hyperoxygenation in Anesthetized Children	N/A
Completed	`NCT04420897` - The Effect of Intraoperative Arterial Oxygen Pressures on Early Post-Operative Patient and Graft Survival in Living Donor Kidney Transplantation
Completed	`NCT03930979` - The Effect of Hyperoxia on Cardiac Output
Not yet recruiting	`NCT06326372` - The Effect of Intraoperative Hyperoxemia on Postoperative Delirium in Geriatric Patients
Recruiting	`NCT05412810` - Oxidative Lipidomic Biomarkers During Mechanical Ventilation in Critically Ill Patients (OXY-BAL).
Completed	`NCT05807815` - The Effectiveness of the Use of Oxygen Reserve Index in Preventing Hyperoxia in the Intensive Care Unit.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Intermittent Normoxia Reduces Myocardial Reperfusion Injury — INCPB

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms